Science Explorer Interactive view Map
Nonprofit · Liverpool · United Kingdom

Roy Castle Lung Cancer Foundation

Research works
77
▼ 33% vs 2013–17
Citations
4.2k
54.3 per fractional work
Top-10% rate
10.5%
record average 16.5%
Open access
46%
world 28%

Not ranked overall: Roy Castle Lung Cancer Foundation is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 0.96× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 0.91× its world share, 0 worksImmunology and Micro…Environmental Science: 0.28× its world share, 0 worksEnvironmental SciencePhysics and Astronomy: 0.13× its world share, 0 worksPhysics and AstronomyHealth Professions: 2.58× its world share, 0 worksHealth ProfessionsMedicine: 3.29× its world share, 3 worksMedicineEconomics, Econometrics and Finance: 7.84× its world share, 1 worksEconomics, Econometr…Social Sciences: 0.44× its world share, 0 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Economics, Econometrics and Finance, 7.8×. Every wedge is a field page.

Which keywords describe research at Roy Castle Lung Cancer Foundation?

By fractional works in all years, weighted toward what it does more of than the world: Targeted Therapy, Clinical Trials, Risk Factors, Preventive Services, Chemotherapy, Cancer Incidence, Population-Based Study and Health Disparities.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Targeted Therapy8▲ 51×3 topics
  2. Clinical Trials8▲ 16×3 topics
  3. Risk Factors7▲ 8.8×6 topics
  4. Preventive Services7▲ 160×2 topics
  5. Chemotherapy7▲ 12×9 topics
  6. Cancer Incidence6▲ 60×2 topics
  7. Population-Based Study6▲ 140×2 topics
  8. Global Surveillance6▲ 205×1 topic
  9. Health Disparities6▲ 40×2 topics
  10. Mortality Rates6▲ 85×1 topic
  11. Cancer6▲ 5.6×22 topics
  12. ALK Inhibitors6▲ 133×1 topic
  13. EGFR Mutations6▲ 133×1 topic
  14. Radiotherapy5▲ 18×5 topics
  15. Cancer Risk5▲ 24×5 topics
  16. Cancer Progression4▲ 26×2 topics
  17. Adjuvant Therapy4▲ 50×2 topics
  18. CT Screening4▲ 100×1 topic
  19. Lung Cancer4▲ 34×2 topics
  20. RNA methylation4▲ 70×1 topic
  21. Tumor Staging4▲ 63×1 topic
  22. m6A-seq4▲ 70×1 topic
  23. Genetic Testing3▲ 27×2 topics
  24. Tumor Suppression3▲ 34×2 topics
  25. Hereditary Syndromes3▲ 104×1 topic
  26. Microsatellite Instability3▲ 104×1 topic
  27. Molecular Characterization3▲ 21×2 topics
  28. DNA Methylation3▲ 32×1 topic
  29. Histone Modification3▲ 56×1 topic
  30. Genomic Instability3▲ 28×3 topics
  31. Cancer Therapy3▲ 5.4×7 topics
  32. Tumor Microenvironment2▲ 8.9×6 topics
  33. Apoptosis2▲ 7.8×6 topics
  34. Precision Medicine2▲ 9.5×5 topics
  35. Cancer Genomics2▲ 45×1 topic
  36. Epigenetic Regulation2▲ 11×3 topics
  37. Mutational Signatures2▲ 45×1 topic
  38. Stem Cells2▲ 8.5×5 topics
  39. Health-related Quality of Life2▲ 11×2 topics
  40. Mutation2▲ 15×2 topics

Which research topics does Roy Castle Lung Cancer Foundation publish most on?

By volume in 2022–2025: Economic and Financial Impacts of Cancer, Global Cancer Incidence and Screening, Cancer survivorship and care and Lung Cancer Diagnosis and Treatment.

  1. 1 Economic and Financial Impacts of Cancer Economics and Econometrics 1 works
  2. 2 Global Cancer Incidence and Screening Oncology 1 works
  3. 3 Cancer survivorship and care Oncology 0 works
  4. 4 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 0 works
  5. 5 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
  6. 6 Patient-Provider Communication in Healthcare General Health Professions 0 works
  7. 7 Childhood Cancer Survivors' Quality of Life Pediatrics, Perinatology and Child Health 0 works
  8. 8 Health Promotion and Cardiovascular Prevention Public Health, Environmental and Occupational Health 0 works
  9. 9 Palliative Care and End-of-Life Issues Public Health, Environmental and Occupational Health 0 works
  10. 10 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available46.3%not open53.7%

World: 28% of research is openly available.

with international co-authors38.5%domestic only61.5%

World: 19% is written across borders.

How has Roy Castle Lung Cancer Foundation's research output changed?

Output in 2018–2022 was 33% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Liverpool

All research institutions in Liverpool

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.